GlassScriptPhysician profile
Zisi Berkowitz
NPI 1578295762
$9,326.45
in general payments reported to CMS, 2019-2025
24 companies · $4,066 in 2025
The $4,066 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $119 · 2023: $954 · 2024: $4,188 · 2025: $4,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,194 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Education: $131 · Travel and Lodging: $83.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,193.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Education | $131.26 |
| Travel and Lodging | $83.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $2,244.23 | 2023-2025 | Opzelura, Opzelura |
| Janssen Biotech, INC. | $1,187.63 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| Dermavant Sciences, INC. | $739.70 | 2023-2024 | Vtama |
| Leo Pharma INC. | $678.23 | 2024-2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $631.62 | 2023-2025 | Zoryve |
| Abbvie INC. | $455.78 | 2024-2025 | |
| Galderma Laboratories, L.P. | $440.60 | 2024-2025 | Nemluvio, Aklief |
| Genzyme Corporation | $380.44 | 2023-2025 | |
| Amgen INC. | $375.56 | 2023-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $361.72 | 2023-2025 | Dupixent, Libtayo |
| Verrica Pharmaceuticals INC. | $311.08 | 2023-2024 | Ycanth |
| Organon LLC | $264.40 | 2025 | Vtama |
| Botanix Sb INC | $249.44 | 2025 | Sofdra |
| Lilly USA, LLC | $248.53 | 2023-2025 | Ebglyss, Taltz, Olumiant |
| Sun Pharmaceutical Industries INC. | $218.47 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $111.31 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $92.67 | 2023-2025 | |
| Epi Health, LLC | $90.13 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $77.66 | 2024-2025 | Sotyktu |
| Ucb, INC. | $62.01 | 2022-2024 | Bimzelx, Cimzia |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $47.11 | 2022-2025 | Jublia, Cabtreo, Arazlo |
| Strata Skin Sciences, INC. | $25.14 | 2024 | Xtrac |
| Convatec INC. | $17.31 | 2024 | |
| Almirall LLC | $15.68 | 2023 | Seysara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zisi Berkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.